IPO registrations (S-1, F-1) · Registrants
JUPITER NEUROSCIENCES, INC.
- SEC CIK
- 1679628 · filings on EDGAR ↗
- Former names
- Jupiter Orphan Therapeutics, Inc. (2016–2017)
- Registration
- Form S-1, first filed 2021-10-12, last 2026-06-26; 3 initial registrations, 22 amendments
- Outcome
- Final prospectus filed 2024-12-02; declared effective 2024-11-08
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 1001 NORTH US HWY 1, SUITE 504, Jupiter, FL 33477
- EIN
- 47-4828381
- Ticker
- JUNS (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- JUPITER NEUROSCIENCES, INC. on the corporate pages
Offering terms
- Proposed price range
- $4.00–$5.00 per share (S-1/A filed 2024-09-13)
- Final price
- $4.00 per share, within the range (424B4 filed 2024-12-02, an initial public offering)
- Shares sold
- 2,750,000
- Gross proceeds
- $11,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol JUNS
- Lead underwriters
- Dominari Securities
- Syndicate
- of Contents; Market, Industry and Other Data; Trademarks and Copyrights
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: JUPITER NEUROSCIENCES, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Federal award recipient: JUPITER NEUROSCIENCES, INC. Fuzzy (name and state)
- Form D issuer: JUPITER NEUROSCIENCES, INC. EXACT (CIK (EXACT))
- SEC filer: JUPITER NEUROSCIENCES, INC. EXACT (CIK (EXACT))
Filings 30
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2021-10-12 | S-1 | S-1 (registration) | JUPITER NEUROSCIENCES, INC. | 0001493152-21-025154 ↗ |
| 2021-11-09 | S-1/A | S-1/A (amendment) | JUPITER NEUROSCIENCES, INC. | 0001493152-21-027617 ↗ |
| 2021-12-17 | S-1/A | S-1/A (amendment) | JUPITER NEUROSCIENCES, INC. | 0001493152-21-031850 ↗ |
| 2021-12-23 | S-1/A | S-1/A (amendment) | JUPITER NEUROSCIENCES, INC. | 0001493152-21-032436 ↗ |
| 2022-01-05 | S-1/A | S-1/A (amendment) | JUPITER NEUROSCIENCES, INC. | 0001493152-22-000453 ↗ |
| 2022-01-26 | S-1/A | S-1/A (amendment) | JUPITER NEUROSCIENCES, INC. | 0001493152-22-002313 ↗ |
| 2022-02-03 | S-1/A | S-1/A (amendment) | JUPITER NEUROSCIENCES, INC. | 0001493152-22-003042 ↗ |
| 2022-02-03 | S-1/A | S-1/A (amendment) | JUPITER NEUROSCIENCES, INC. | 0001493152-22-003091 ↗ |
| 2022-04-26 | S-1/A | S-1/A (amendment) | JUPITER NEUROSCIENCES, INC. | 0001493152-22-011151 ↗ |
| 2022-05-04 | S-1/A | S-1/A (amendment) | JUPITER NEUROSCIENCES, INC. | 0001493152-22-012044 ↗ |
| 2022-05-05 | S-1/A | S-1/A (amendment) | JUPITER NEUROSCIENCES, INC. | 0001493152-22-012197 ↗ |
| 2022-05-18 | S-1/A | S-1/A (amendment) | JUPITER NEUROSCIENCES, INC. | 0001493152-22-014343 ↗ |
| 2022-08-16 | S-1/A | S-1/A (amendment) | JUPITER NEUROSCIENCES, INC. | 0001493152-22-023233 ↗ |
| 2022-08-26 | S-1/A | S-1/A (amendment) | JUPITER NEUROSCIENCES, INC. | 0001493152-22-024119 ↗ |
| 2022-12-02 | S-1/A | S-1/A (amendment) | JUPITER NEUROSCIENCES, INC. | 0001493152-22-034319 ↗ |
| 2022-12-07 | S-1/A | S-1/A (amendment) | JUPITER NEUROSCIENCES, INC. | 0001493152-22-034670 ↗ |
| 2023-01-06 | S-1/A | S-1/A (amendment) | JUPITER NEUROSCIENCES, INC. | 0001493152-23-000795 ↗ |
| 2023-01-17 | S-1/A | S-1/A (amendment) | JUPITER NEUROSCIENCES, INC. | 0001493152-23-001540 ↗ |
| 2024-07-12 | S-1/A | S-1/A (amendment) | JUPITER NEUROSCIENCES, INC. | 0001493152-24-027145 ↗ |
| 2024-09-04 | S-1/A | S-1/A (amendment) | JUPITER NEUROSCIENCES, INC. | 0001493152-24-034903 ↗ |
| 2024-09-04 | S-1/A | S-1/A (amendment) | JUPITER NEUROSCIENCES, INC. | 0001493152-24-035002 ↗ |
| 2024-09-13 | S-1/A | S-1/A (amendment) | JUPITER NEUROSCIENCES, INC. | 0001493152-24-036247 ↗ |
| 2024-10-18 | S-1/A | S-1/A (amendment) | JUPITER NEUROSCIENCES, INC. | 0001493152-24-041537 ↗ |
| 2024-11-08 | EFFECT | EFFECT (declared effective) | JUPITER NEUROSCIENCES, INC. | 9999999995-24-003407 ↗ |
| 2024-12-02 | 424B4 | 424B4 (final prospectus) | JUPITER NEUROSCIENCES, INC. | 0001493152-24-048318 ↗ |
| 2025-11-26 | S-1 | S-1 (registration) | JUPITER NEUROSCIENCES, INC. | 0001493152-25-025204 ↗ |
| 2025-12-11 | EFFECT | EFFECT (declared effective) | JUPITER NEUROSCIENCES, INC. | 9999999995-25-003679 ↗ |
| 2026-04-24 | EFFECT | EFFECT (declared effective) | JUPITER NEUROSCIENCES, INC. | 9999999995-26-001329 ↗ |
| 2026-06-26 | S-1 | S-1 (registration) | JUPITER NEUROSCIENCES, INC. | 0001493152-26-030312 ↗ |
| 2026-07-07 | EFFECT | EFFECT (declared effective) | JUPITER NEUROSCIENCES, INC. | 9999999995-26-002213 ↗ |
Prospectus pages read 3
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-13 | S-1/A | registration statement | $4.00–$5.00 | 2,750,000 | - | Nasdaq JUNS | 4 | primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 3 | document ↗ | |
| 2024-10-18 | S-1/A | registration statement | - | - | 0 | primary document; no terms found | document ↗ | |||
| 2024-12-02 | 424B4 | final prospectus | $4.00 | 2,750,000 | $11,000,000 | Nasdaq JUNS | 4 | primary document; price sentence, shares headline, proceeds table, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Brady Allison W | Director | 3 | 2024–2026 | ||
| Elmasri Saleem | Officer | CFO and Secretary; Chief Financial Officer | 3 | 2024–2026 | |
| Hayward Marshall A. | Director,Officer | Chief Scientific Officer | 3 | 2024–2026 | |
| Hemmerly Nicholas H. | Director | 3 | 2024–2026 | ||
| Kampf Julie B. | Director | 3 | 2024–2026 | ||
| Rosen Alexander Gustaf Erik | Officer | Chief Administrative Officer | 3 | 2024–2026 | |
| ROSEN CHRISTER | Director,Officer; Director,Officer,TenPercentOwner | CEO and Chairman; Chairman and CEO | 4 | 2024–2026 | |
| Silva Alison D. | Director,Officer; Officer | Pres + Chief Business Officer; President and COO | 5 | 2024–2026 | |
| Weis Holger | Director | 4 | 2024–2026 | ||
| Wahlestedt Claes Robert | TenPercentOwner | 1 | 2024 | ||
| Philipson Tomas Jan | Director | 2 | 2026 | ||
| Cutler Andrew Jon | Director | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2026-09-04 | JUPITER NEUROSCIENCES, INC. | Other Health Care | $774,787 | $774,787 | 1 | 1 |
| 2017-12-05 | Jupiter Orphan Therapeutics, Inc. | Other Health Care | $100,000 | $100,000 | 1 | 1 |
| 2016-12-28 | Jupiter Orphan Therapeutics, Inc. | Other Health Care | $1,001,000 | $1,001,000 | 1 | 1 |
| 2016-07-15 | Jupiter Orphan Therapeutics, Inc. | Other Health Care | $4,500,000 | $250,000 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | JUPITER NEUROSCIENCES, INC. | FL | State business registries | name and state |
| Federal award recipient | JUPITER NEUROSCIENCES, INC. | FL | Federal spending (USAspending) | name and state |
| Form D issuer | JUPITER NEUROSCIENCES, INC. | FL | Form D private offerings | CIK (EXACT) |
| SEC filer | JUPITER NEUROSCIENCES, INC. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Jupiter Neurosciences, Inc. | FL | Trademarks (USPTO) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, FL first:
- SANO CORP FL
- CTT PHARMACEUTICAL HOLDINGS, INC. FL
- Inhibitor Therapeutics, Inc. FL
- GENEREX BIOTECHNOLOGY CORP FL
- BIOMOLECULAR LIFE HOLDINGS, INC. FL
- Alaunos Therapeutics, Inc. FL
- ORAGENICS INC FL
- Polomar Health Services, Inc. FL
- ACCENTIA BIOPHARMACEUTICALS INC FL
- NOMAD POWER SOLUTIONS, INC. FL
In other datasets, the same topic (Health) in FL:
- Nonprofit: 414 WELLWOMEN INC (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health